İçeriğe geç
debya
Türkçe
Giriş yap Ücretsiz üye ol
Bluesky’da aç Bu hesabı takip et

Cambridge Clinical Mitochondrial Research Group

@mitocamb.bsky.social did:plc:fktekiurn2gua5i4kvysc4rq

MitoCAMB brings together a team of clinical researchers focused on mitochondrial and neurodegenerative disease translational research. mitocamb.medschl.cam.ac.uk (Photo: Florian Klimm)

Bluesky’a katılma tarihi:

Takipçi
384
Takip edilen
266
Post
80
Sıralamaya girdiği gün
0

Özet

Cambridge Clinical Mitochondrial Research Group (@mitocamb.bsky.social), 3 Ocak 2025 tarihinde katılan bir Bluesky kullanıcısı. 384 takipçisi var, 266 hesabı takip ediyor ve 80 post paylaştı.

Sıralama geçmişi

Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.

Bu hesap henüz günlük sıralamaya girmedi.

Son beğendiği postlar

Bluesky ağındaki herkese açık beğeniler.

  • The Lily Foundation@lilyfoundation.bsky.social

    🎓 Congratulations to our Head of Patient Support & Advocacy, Katie, who graduated from the EUPATI Patient Expert Training Programme after completing her final week of training in Barcelona! Katie's training will strengthen our expertise in helping patients shape research #mitochondrialdisease #mito

    Postu göster
  • LifeArc@lifearc.bsky.social

    Meaningful patient involvement in rare disease research doesn't happen by chance. It requires funding, infrastructure, recognition and commitment. Our new co-authored peer-reviewed commentary explored how PPIE can be embedded across the research pathway. Read now: https://t.ly/vggqd

    Postu göster
  • Department of Pharmacology | University of Cambridge@phar.cam.ac.uk

    Black History Month Talk - Nina Chhita, Monday 26 October, 13:00 In celebration of this year’s Black History Month, we have invited Nina Chhita as our speaker for a talk on The Healers of Harlem: The Black Women Who Changed Medicine Forever More info: talks.cam.ac.uk/talk/index/2...

    Postu göster
  • LifeArc@lifearc.bsky.social

    What could the next generation of genetic medicines mean for people with rare diseases? Experts at our Translational Science Summit earlier this year explored the opportunities and challenges shaping the field. Catch up with the accessible summaries: https://bit.ly/3UY0Fr4

    Postu göster
  • Kapalı hesap

    İçerik görüntülenemiyor

    Postu göster

Daha fazlası için üye girişi yap

Blokladığı hesaplar

Bluesky’da bloklar herkese açık kayıtlardır.

Bu hesap kimseyi bloklamıyor.